It looks like much of the world is emerging from a summer of COVID and is now on the downward side of the epidemic curve.
Earlier this week, a formal internal advisory report from the US FDA said that the data did support boosters for the general population.
As of the middle of this week, new case rates are down in more than half of the United States and the overall rate is down approximately 5%.
Over the last week, between 5 and 10% of US states have seen a downward trend in the number of cases, but, the overall upward trend in the US has not turned around.
The big news of the last week is that the first Covid vaccine has been fully approved for full licensure in the United States.
The FDA authorized what is not a booster, but guidance that primary immunization for immunocompromised individuals should consist of 3 shots.
The major discussion this week is whether Delta is crowding out other variants so rapidly it will run out of susceptible hosts over a 6-8 week period.
For the fourth week in a row, COVID cases averaged across the United States have increased by about 50%, at 27 cases per 100,000 per day.
The effects of the delta variant have changed both the public and governmental attitudes away from a sense of being nearly over this.
North American and European Nations appear to have run into a wall on vaccination acceptance at about 50% of the population fully vaccinated.